Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Nearly 1 in 5 Emergency Department Prescriptions Yield Pharmacist Intervention
06/01/2021
Jolynn Tumolo
“When necessary, emergency medicine pharmacists discussed recommendations with prescribers, or adjusted prescriptions according to institutional pharmacist privileges,” wrote researchers.
“When necessary, emergency medicine pharmacists discussed recommendations with prescribers, or adjusted prescriptions according to institutional pharmacist privileges,” wrote researchers.
“When necessary, emergency...
06/01/2021
Pharmacy Learning Network
News
Review Finds Flaws in Cost-Avoidance Studies of Pharmacist Interventions
05/21/2021
“This scoping review summarizes, critiques, and identifies current limitations of the methods that have been used to determine cost avoidance associated with pharmacists’ interventions in acute care settings,” wrote researchers.
“This scoping review summarizes, critiques, and identifies current limitations of the methods that have been used to determine cost avoidance associated with pharmacists’ interventions in acute care settings,” wrote researchers.
“This scoping review summarizes,...
05/21/2021
Pharmacy Learning Network
News
Multidisciplinary Intervention Has No Significant Effect on Heart Failure Readmissions
05/21/2021
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational...
05/21/2021
Pharmacy Learning Network

Advertisement

News
Diabetes Drug Recalled Over Foreign Substance
05/21/2021
Sun Pharmaceutical Industries Inc is voluntarily recalling 50,868 bottles of metformin hydrochloride extended-release tablets due to the presence of a foreign substance identified as activated carbon.
Sun Pharmaceutical Industries Inc is voluntarily recalling 50,868 bottles of metformin hydrochloride extended-release tablets due to the presence of a foreign substance identified as activated carbon.
Sun Pharmaceutical Industries...
05/21/2021
Pharmacy Learning Network
News
Antiviral Tablets Recalled
05/13/2021
A recall is active for a prescription antiviral medication used to treat herpes virus infections.
A recall is active for a prescription antiviral medication used to treat herpes virus infections.
A recall is active for a...
05/13/2021
Pharmacy Learning Network
News
Class I Recall for Hand Sanitizer that Resembles Water Bottles
05/13/2021
According to the recent FDA Enforcement Report, 139,806 bottles of Heal the World hand sanitizer is packaged in containers resembling water bottles.
According to the recent FDA Enforcement Report, 139,806 bottles of Heal the World hand sanitizer is packaged in containers resembling water bottles.
According to the recent FDA...
05/13/2021
Pharmacy Learning Network

Advertisement

News
Pain Reliever in Kits Distributed by Humana Involved in Class I Recall
05/13/2021
A-S Medication Solutions is recalling extra-strength acetaminophen included in Health Essentials Kits that Humana distributed to members.
A-S Medication Solutions is recalling extra-strength acetaminophen included in Health Essentials Kits that Humana distributed to members.
A-S Medication Solutions is...
05/13/2021
Pharmacy Learning Network
News
Spinal Muscular Atrophy Drug Recalled
05/06/2021
A nationwide recall is active for a prescription drug used to treat spinal muscular atrophy.
A nationwide recall is active for a prescription drug used to treat spinal muscular atrophy.
A nationwide recall is active...
05/06/2021
Pharmacy Learning Network
News
Blood Pressure Drug Recalled
05/06/2021
A Class II recall is active for a prescription drug used to treat high blood pressure.
A Class II recall is active for a prescription drug used to treat high blood pressure.
A Class II recall is active for...
05/06/2021
Pharmacy Learning Network

Advertisement

News
Steroid Ointment Recalled
05/06/2021
A recall is active for a prescription steroid used to treat a variety of skin conditions, such as eczema, dermatitis, and rash.
A recall is active for a prescription steroid used to treat a variety of skin conditions, such as eczema, dermatitis, and rash.
A recall is active for a...
05/06/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use